Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 May;49(5):3000605211016761.
doi: 10.1177/03000605211016761.

HIV-negative case of Talaromyces marneffei pulmonary infection with a TSC2 mutation

Affiliations
Case Reports

HIV-negative case of Talaromyces marneffei pulmonary infection with a TSC2 mutation

Qian Shen et al. J Int Med Res. 2021 May.

Abstract

Talaromyces marneffei is a rare dimorphic pathogenic fungus that can induce severe infections in human immunodeficiency virus (HIV)-infected patients. However, such infections have also been reported in non-HIV hosts. This current case report describes a very rare case of a T. marneffei pulmonary infection in an HIV-negative patient with a mutation in the tuberous sclerosis complex subunit 2 (TSC2) gene. A 24-year-old male patient presented with cough and expectoration for 6 months. Computed tomography showed multiple ground-glass opacities and cystic and cavitated lesions in both lungs. Next generation sequencing (NGS) of the bronchoalveolar lavage fluid was performed to confirm T. marneffei pulmonary infection. The results were further verified using bronchoscopy specimen cultures. This was an HIV-negative patient without a travel history to endemic zones and his blood exon sequencing results showed a mutation in the TSC2 gene. To date, he has recovered well with voriconazole therapy. In summary, patients with TSC2 mutations that induce bronchopulmonary dysplasia may be potential hosts for T. marneffei. Early and timely diagnosis is important for improving prognosis. NGS plays a critical role in the diagnosis of T. marneffei pulmonary infection.

Keywords: HIV-negative; TSC2; Talaromyces marneffei; pulmonary infection.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interest: The authors declare that there are no conflicts of interest.

Figures

Figure 1.
Figure 1.
Representative computed tomography (CT) imaging scans of a 24-year-old male patient that presented with a 6-month history of recurrent cough and expectoration without fever, shortness of breath or chest pain. (A) CT scan taken in February 2019 showing multiple ground glass opacities, cystic changes and cavitated lesions in both lungs. (B) CT scan taken in March 2019 showing the ground glass shadows were absorbed. (C & D) CT scans taken during follow-up in September 2019 and June 2020, respectively, showing distinct resolution of lesions in both lungs, except for the cystic lesions.
Figure 2.
Figure 2.
Representative bronchoscopic examinations of a 24-year-old male patient that presented with a 6-month history of recurrent cough and expectoration without fever, shortness of breath or chest pain demonstrated that both bronchi were clear (A–D). Endobronchial ultrasound showing a mass at the subbranch of the right lower lobe bronchial dorsal (E). The colour version of this figure is available at: http://imr.sagepub.com.
Figure 3.
Figure 3.
Cultures of the bronchoalveolar lavage fluid (BALF) from a 24-year-old male patient that presented with a 6-month history of recurrent cough and expectoration without fever, shortness of breath or chest pain. (A) Fungal spores seen in phagocytes from BALF (red arrow) (scale bar 15 µm). (B) Culture of BALF revealed Talaromyces marneffei, which showed temperature-dependent dimorphic growth characteristics and the cells produced a soluble red pigment at 25 °C. (C) A mycelium was produced at temperatures between 25 °C and 30 °C. (D) Fungus growing as yeast-like cells at 37 °C. The colour version of this figure is available at: http://imr.sagepub.com.
Figure 4.
Figure 4.
Sanger sequencing verification results for a 24-year-old male patient and his parents. The patient and his father carried a mutation in the tuberous sclerosis complex subunit 2 (TSC2) gene and his mother was wild-type. The colour version of this figure is available at: http://imr.sagepub.com.

References

    1. Lau SKP, Tsang CC, Woo PCY. Talaromyces marneffei Genomic, Transcriptomic, Proteomic and Metabolomic Studies Reveal Mechanisms for Environmental Adaptations and Virulence. Toxins (Basel ) 2017; 9: 192. - PMC - PubMed
    1. Hu Y, Zhang J, Li X, et al.. Penicillium marneffei infection: an emerging disease in mainland China. Mycopathologia 2013; 175: 57–67. - PubMed
    1. Vanittanakom N, Cooper CR, Jr, Fisher MC, et al.. Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects. Clin Microbiol Rev 2006; 19: 95–110. - PMC - PubMed
    1. Pasricha S, MacRae JI, Chua HH, et al.. Extensive Metabolic Remodeling Differentiates Non-pathogenic and Pathogenic Growth Forms of the Dimorphic Pathogen Talaromyces marneffei. Front Cell Infect Microbiol 2017; 7: 368. - PMC - PubMed
    1. Li HR, Cai SX, Chen YS, et al.. Comparison of Talaromyces marneffei Infection in Human Immunodeficiency Virus-positive and Human Immunodeficiency Virus-negative Patients from Fujian, China. Chin Med J (Engl) 2016; 129: 1059–1065. - PMC - PubMed

Publication types

Supplementary concepts